ImmuneOnco Biopharmaceuticals (Shanghai) Co.
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $130M
Investors
- 11
About ImmuneOnco Biopharmaceuticals (Shanghai) Co.
, Ltd. operates as a biopharmaceutical company that develops novel immunotherapy for patients with cancer. The company was founded by its CEO Wenzhi Tian. ImmuneOnco Biopharmaceuticals focuses on the development and research of anti-tumor immunotherapy products such as bispecific antibodies and new recombinant proteins. The company also provides Target-Activated NK (TANK™) Cell Therapy and Macrophages which help to detect and kill target cancer cells.
Who invested in ImmuneOnco Biopharmaceuticals (Shanghai) Co.
11 investors across 3 rounds
See all investors in ImmuneOnco Biopharmaceuticals (Shanghai) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImmuneOnco Biopharmaceuticals (Shanghai) Co.
Who invested in ImmuneOnco Biopharmaceuticals (Shanghai) Co.?
ImmuneOnco Biopharmaceuticals (Shanghai) Co. has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmuneOnco Biopharmaceuticals (Shanghai) Co. raised?
ImmuneOnco Biopharmaceuticals (Shanghai) Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ImmuneOnco Biopharmaceuticals (Shanghai) Co. last raise money?
ImmuneOnco Biopharmaceuticals (Shanghai) Co.'s most recent round on record is a Series C, in Mar 2021.
What does ImmuneOnco Biopharmaceuticals (Shanghai) Co. do?
ImmuneOnco Biopharmaceuticals (Shanghai) Co. is a biotechnology company.
Where is ImmuneOnco Biopharmaceuticals (Shanghai) Co. headquartered?
ImmuneOnco Biopharmaceuticals (Shanghai) Co. is headquartered in Shanghai, China.
Which VCs invest in companies like ImmuneOnco Biopharmaceuticals (Shanghai) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ImmuneOnco Biopharmaceuticals (Shanghai) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ImmuneOnco Biopharmaceuticals (Shanghai) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.